Gullans Steven R. Ph.D. 4
4 · Gemphire Therapeutics Inc. · Filed May 3, 2018
Insider Transaction Report
Form 4
Gullans Steven R. Ph.D.
Director
Transactions
- Award
Employee Stock Option (right to buy)
2018-05-01+150,000→ 150,000 totalExercise: $5.56Exp: 2028-04-30→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]The option vests in a series of 48 successive equal monthly installments on the last day of each month, commencing on the grant date. The option includes an early exercise provision, subject to the issuer's right of repurchase with respect to any unvested shares of common stock.
- [F2]The reporting person ceased to be a manager of Excel Venture Fund II, L.P. on May 1, 2018 and will no longer report beneficial ownership of the issuer's securities owned by such entity.